Additionally, a study in non-small cell lung cancer demonstrated that high CCAR2 expression was positively correlated with the efficacy of cisplatin, further suggesting that CCAR2 has a chemosensitizing function as a new target for overcoming chemoresistance in HCC 27. This evidence concerns the gene CCAR2 and hepatocellular carcinoma.